Employees
717
Industry
Biological Product (except Diagnostic) Manufacturing
freeline is a biopharmaceutical company focused on the development and commercialisation of gene therapies for bleeding and other debilitating disorders based on a next-generation aav gene therapy platform developed by amit nathwani, professor of haematology at ucl and cso of freeline therapeutics http://www.freelinetx.com
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Charles Gross
October 18, 2023 | 10:15 am
Portfolio Pulse from Benzinga Newsdesk
October 16, 2023 | 11:18 am
Portfolio Pulse from Benzinga Insights
October 09, 2023 | 5:31 pm
Portfolio Pulse from Benzinga Insights
October 06, 2023 | 1:06 pm
Portfolio Pulse from Benzinga Insights
October 05, 2023 | 9:32 pm
Portfolio Pulse from Vandana Singh
October 04, 2023 | 2:23 pm
Portfolio Pulse from Benzinga Insights
October 04, 2023 | 1:06 pm
Portfolio Pulse from ryanfaloona@benzinga.com
October 04, 2023 | 12:43 pm
Portfolio Pulse from Benzinga Newsdesk
October 04, 2023 | 12:36 pm
Portfolio Pulse from Benzinga Newsdesk
October 04, 2023 | 11:02 am
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.